DOGWOOD THERAPEUTICS INC (DWTX:NASDAQ)

$2.04 -0.25 (-10.917%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 82

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed DOGWOOD THERAPEUTICS INC (DWTX:NASDAQ) News Sources

Chemotherapy-Induced Peripheral Neuropathy Market to Witness Significant Growth at a CAGR of 14.2% During the Forecast Period (2026-2036) as Novel Therapies Enter Late-Stage Development | DelveInsight

16-06-2026

yahoo.com

Dogwood Therapeutics Announces FDA Acceptance of SP16 Investigational New Drug Application for the Treatment of Chemotherapy Induced Pain and Neuropathy

15-04-2026

yahoo.com

Dogwood Therapeutics Announces Worldwide Development and Commercialization Partnership for Anti-Viral Assets with Potential Value up to $100M

23-04-2026

yahoo.com

Dogwood Therapeutics to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026

07-05-2026

yahoo.com

Dogwood Therapeutics Announces Commencement of Halneuron® Chemotherapy Induced Neuropathic Pain Phase 2b Long Term Extension Study

18-05-2026

yahoo.com

Dogwood Therapeutics Appoints Iain Dukes, Venture Partner at OrbiMed, as Chair of Scientific Advisory Board

30-06-2026

yahoo.com

Dogwood Enrolls First 200 Patients in Ongoing Halneuron® Phase 2b Chemotherapy Induced Neuropathy Trial; Top-line Data Expected in Fall 2026

20-07-2026

yahoo.com

Dogwood Therapeutics Announces Second Quarter 2026 Financial Results

13-08-2026

yahoo.com

Dogwood to Host Virtual KOL Event to Discuss Halneuron® for the Treatment of Chemotherapy Induced Neuropathic Pain on September 1, 2026

17-08-2026

yahoo.com

Dogwood Therapeutics Nears Phase 2b Readout for Halneuron Neuropathic Pain Treatment

01-09-2026

marketbeat.com

DOGWOOD THERAPEUTICS INC (DWTX:NASDAQ) Sentiment Trend

0 25 50 75 100 88 78 86 76 75 80 82 85 81 88 16-06-2026 15-04-2026 23-04-2026 07-05-2026 18-05-2026 30-06-2026 20-07-2026 13-08-2026 17-08-2026 01-09-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

DOGWOOD THERAPEUTICS INC (DWTX:NASDAQ) FAQs

toggle

What is the current price of DOGWOOD THERAPEUTICS INC (DWTX:NASDAQ)?

The current price of DOGWOOD THERAPEUTICS INC (DWTX:NASDAQ) is $2.04.


toggle

DOGWOOD THERAPEUTICS INC (DWTX:NASDAQ) absolute price change since previous trading day?

The absolute price change of DOGWOOD THERAPEUTICS INC (DWTX:NASDAQ) since the previous trading day is $-0.25.


toggle

DOGWOOD THERAPEUTICS INC (DWTX:NASDAQ) percentage price change since previous trading day?

The percentage price change of DOGWOOD THERAPEUTICS INC (DWTX:NASDAQ) since the previous trading day is -10.917%.


toggle

What is the most recent average sentiment score for DOGWOOD THERAPEUTICS INC (DWTX:NASDAQ)?

The most recent average sentiment score for DOGWOOD THERAPEUTICS INC (DWTX:NASDAQ) is 82 out of 100.


toggle

What is the most recent average sentiment for DOGWOOD THERAPEUTICS INC (DWTX:NASDAQ)?

The most recent sentiment for DOGWOOD THERAPEUTICS INC (DWTX:NASDAQ) is .


SEC-8K** Filing Available For DOGWOOD THERAPEUTICS INC (DWTX:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.